These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12048276)

  • 1. Re: All-cause mortality in randomized trials of cancer screening.
    Parker C; Dearnaley D
    J Natl Cancer Inst; 2002 Jun; 94(11):861-2; author reply 865-6. PubMed ID: 12048276
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant hormone therapy in locally advanced and localized prostate cancer: three EORTC trials.
    Bolla M; de Reijke TM; Zurlo A; Collette L
    Front Radiat Ther Oncol; 2002; 36():81-6. PubMed ID: 11842758
    [No Abstract]   [Full Text] [Related]  

  • 3. RTOG study shows improved survival for prostate cancer patients given adjuvant goserelin.
    Oncology (Williston Park); 2005 Aug; 19(9):1142. PubMed ID: 16402596
    [No Abstract]   [Full Text] [Related]  

  • 4. Goserelin-induced depression in a man with prostate cancer.
    Ahmadi-Davis S; Velasco R; Stewart JT
    Psychosomatics; 2014; 55(6):720-2. PubMed ID: 24629897
    [No Abstract]   [Full Text] [Related]  

  • 5. ASTRO plenary session touts top new research. American Society for Therapeutic Radiology and Oncology.
    Volkers N
    J Natl Cancer Inst; 1999 Dec; 91(24):2075-7. PubMed ID: 10601375
    [No Abstract]   [Full Text] [Related]  

  • 6. Goserelin.
    Nurs Times; 2006 Jan 17-23; 102(3):41. PubMed ID: 16440976
    [No Abstract]   [Full Text] [Related]  

  • 7. [Zoladex (ICI) in the therapy of prostatic cancer patients].
    Popko AS; Dokshin KL
    Urol Nefrol (Mosk); 1996; (6):53-5. PubMed ID: 9036615
    [No Abstract]   [Full Text] [Related]  

  • 8. [Zoladex: new approaches to hormone therapy].
    Shparyk IaV
    Lik Sprava; 1996; (5-6):44-50. PubMed ID: 9377399
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: All-cause mortality in randomized trials of cancer screening.
    Weiss NS; Koepsell TD
    J Natl Cancer Inst; 2002 Jun; 94(11):864-5; author reply 865-6. PubMed ID: 12048281
    [No Abstract]   [Full Text] [Related]  

  • 10. Rapid onset of pituitary apoplexy after goserelin implant for prostate cancer: need for heightened awareness.
    Eaton HJ; Phillips PJ; Hanieh A; Cooper J; Bolt J; Torpy DJ
    Intern Med J; 2001 Jul; 31(5):313-4. PubMed ID: 11512605
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostate cancer--the therapeutic challenge of locally advanced disease.
    Blasko JC; Lange PH
    N Engl J Med; 1997 Jul; 337(5):340-1. PubMed ID: 9233872
    [No Abstract]   [Full Text] [Related]  

  • 12. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin.
    Bolla M; Gonzalez D; Warde P; Dubois JB; Mirimanoff RO; Storme G; Bernier J; Kuten A; Sternberg C; Gil T; Collette L; Pierart M
    N Engl J Med; 1997 Jul; 337(5):295-300. PubMed ID: 9233866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characteristics, effects, side effects of the LH-RH agonist].
    Miyanaga N; Akaza H
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():177-81. PubMed ID: 12599567
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: All-cause mortality in randomized trials of cancer screening.
    Begg CB; Bach PB
    J Natl Cancer Inst; 2002 Jun; 94(11):863-4; author reply 865-6. PubMed ID: 12048279
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: All-cause mortality in randomized trials of cancer screening.
    Church TR; Ederer F; Mandel JS
    J Natl Cancer Inst; 2002 Jun; 94(11):861; author reply 865-6. PubMed ID: 12048277
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of prostate cancer with goserelin and radiotherapy.
    Vicini FA; Kini VR; Martinez AA
    N Engl J Med; 1997 Dec; 337(23):1693-4. PubMed ID: 9411236
    [No Abstract]   [Full Text] [Related]  

  • 17. Disease control outcomes from analysis of pooled individual patient data from five comparative randomised clinical trials of degarelix versus luteinising hormone-releasing hormone agonists.
    Klotz L; Miller K; Crawford ED; Shore N; Tombal B; Karup C; Malmberg A; Persson BE
    Eur Urol; 2014 Dec; 66(6):1101-8. PubMed ID: 24440304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of local cooling at injection site of goserelin acetate for pain relief].
    Nukui A; Morita T
    Gan To Kagaku Ryoho; 2011 Jun; 38(6):967-72. PubMed ID: 21677488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prostate cancer conundrum.
    Albertsen PC
    J Natl Cancer Inst; 2003 Jul; 95(13):930-1. PubMed ID: 12837821
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: All-cause mortality in randomized trials of cancer screening.
    Gail MH; Katki HA
    J Natl Cancer Inst; 2002 Jun; 94(11):862; author reply 865-6. PubMed ID: 12048278
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.